Support and monitor quality and value
Use proven clinical governance principles to achieve safe, high-quality genomic care.
Robust clinical governance is essential for ensuring genomic care that is safe, timely, effective, efficient, equitable, and person-centred. This webpage can help support your health service improve organisation-wide understanding and monitoring of the quality and safety of the genomic care it provides.
This webpage includes a set of principles and considerations to guide health services in their approach to achieving high quality, value-based genomic care, and a list of recommended metrics to monitor progress towards this goal.
Support and monitor quality, safety and value is a key action in the Genomics in Your Hospital toolkit, designed with hospitals in Victoria.
- What should be considered in implementing and monitoring safe, effective and value based genomic care?
- When and how should genomic care be reviewed?
- Tool: Resources to help support hospitals achieve and monitor safe, effective and high-quality genomic care
- How were these tools developed?
What should be considered when implementing and monitoring safe, effective, value based genomic care?
Genomic care is not standalone and should be reviewed in the context of your local clinical governance framework, capabilities and needs. The seven actions in the Genomics and Your Hospital toolkit link to the domains covered in Safer Care Victoria’s Clinical Governance Framework. These domains are reflected in the resource linked below.
It’s recommended your health service’s genomics leadership group or executive sponsor establish clear accountabilities for achieving safe, high quality, value based genomic care and determine optimal monitoring and escalation pathways.
When and how should genomic care be reviewed?
Like other aspects of healthcare, genomic medicine should operate in a cycle of continuous improvement.
This tool can help hospitals determine what is important to measure when it comes to quality, safety and value of genomic care. It also contains recommendations about when to review the data. This includes deciding what needs to be monitored on a routine basis, and what should be reviewed annually to inform good decision making.
Tool: Resources to support hospitals achieve and monitor safe, effective and high-quality genomic care
This resource can guide your hospital’s genomics leadership group design a comprehensive approach to achieving quality genomic care. They are aligned with existing clinical governance frameworks and emphasise:
- Leadership, governance, and a culture of safety
- Continuous monitoring, improvement, and risk management
- Person-centred, equitable care
This resource also contains a list of suggested metrics to consider when measuring quality, safety and value of genomic care. Understanding that hospitals have different capacities and constraints in data capture, this tool is intended to offer guidance rather than prescribing a way forward.
How were these tools developed?
The principles and metrics above were developed by the Quality Working Group, set up by the Melbourne Genomics Health Alliance.
The group comprised 14 healthcare leaders, clinical specialists and consumer advocates, bringing together expertise in quality measurement, implementation of new technology and clinical practice, hospital data systems, genomics, health economics, and consumer involvement.
The working group first established a set of principles relevant to genomic care, then drafted and rated a list of metrics to help hospitals measure quality and value.
© MGHA 2024. These materials were prepared by the Melbourne Genomics Health Alliance (MGHA) and are protected by copyright. We would like to acknowledge the expertise and knowledge of those who have contributed to the development of these materials. Reproduction or distribution of these materials without this notice is prohibited.